A controlled study of intravesical epirubicin with or without alpha2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.1995.tb00759.x/fullpdf
Reference23 articles.
1. Superficial bladder cancer: risk of recurrence and potential role for interferon therapy;Torti;Cancer,1987
2. Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group;Dalesio;J Urol,1983
3. Ta and T1 bladder cancer: location, recurrence and progression;Heney;Br J Urol,1982
4. Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study;Melekos;J Urol,1992
5. Multi-centre phase II study of low dose intravesical epirubicin in the treatment of superficial bladder cancer;Whelan;Br J Urol,1991
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guérin Is Unavailable;European Urology Oncology;2020-10
2. Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non–Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study;European Urology;2016-08
3. Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2016-07-08
4. 5-Year Outcome of a Randomized Prospective Study Comparing bacillus Calmette-Guérin with Epirubicin and Interferon-α2b in Patients with T1 Bladder Cancer;Journal of Urology;2014-05
5. Cancer Immunotherapy;Cancer Biotherapy and Radiopharmaceuticals;2011-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3